Massachusetts-based drug developer Acrivon Therapeutics aims to raise $100M through its initial public offering in what is shaping up to be one of the...

Consumer products platform provider Aterian (US:ATER) reported third quarter earnings to investors after the close of trading on Tuesday. The stock traded -3.8% lower...

Here are several analyst research calls made just before Wednesday's opening bell.

Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two Interactive Software, Viatris and Walgreens Boots Alliance.

After U.S. markets close Thursday, Aurora Cannabis and Toast will report quarterly results. Here's what to look for.

More research calls released during Wednesday's premarket trading session.

The big question for investors looking for bargains after the big-tech meltdown is which ones to go after now. Goldman Sachs favors these five outstanding software stocks, and some have huge upside to the target prices.

Here are early analyst research calls for Wednesday morning.

Here is a look at the five best and worst performing large-cap stocks in October 2022.

Crown Holdings (US:CCK) said on Monday that its board set a shareholder rights plan, commonly called a poison pill, to defend against activist Carl...